Spotlight On Neuroendocrine Carcinomas
Here to help shine a light on a group of rare and aggressive cancers is Spotlight On Neuroendocrine Carcinomas. Through expert-led discussions and in-depth articles focusing on diagnosis, staging, and management strategies, this series dives into the complexities that set neuroendocrine carcinomas apart.
Episodes 1-9 of 9
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
SCNEC Diagnosis: Cytological Clues to a Rare Cervical Malignancy
Project Oncology®SCNEC Diagnosis: Cytological Clues to a Rare Cervical Malignancy
Impact of DLL3-Directed Immunotherapy on the Small Cell Lung Cancer Landscape
Project Oncology®Impact of DLL3-Directed Immunotherapy on the Small Cell Lung Cancer Landscape
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
Project Oncology®Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
Project Oncology®The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
- advertisement
Diagnosing LCNEC of the Lung: Challenges and Strategies
Project Oncology®Diagnosing LCNEC of the Lung: Challenges and Strategies
Personalizing Care for Large Cell Neuroendocrine Carcinoma
Project Oncology®Personalizing Care for Large Cell Neuroendocrine Carcinoma
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Project Oncology®DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
